Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and ...

CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in certain patients with locally advanced head and neck squamous cell ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...